Low molecular weight heparins: the optimal treatment for venous thromboembolism

Author： Daskalopoulos Marios E.   Daskalopoulou Stella S.   Liapis Christos D.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.20, Iss.7, 2004-07, pp. : 1001-1005

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Home Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 83-84

Karger

Access to resources Recommend Favorite

Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 2, 2003-11 ,pp. : 64-67

Karger

Access to resources Recommend Favorite

Does Low-Molecular-Weight Heparin Reduce the Costs of Venous Thromboembolism Treatment?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 1, 2001-06 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Unfractionated Heparin and Low-Molecular-Weight Heparin for the Initial Treatment of Acute Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite